Deepinder Goyal’s Temple valuation jumps 2X after ESOP liquidity

•Deepinder Goyal's Temple healthtech startup doubled its valuation to $375 million after a secondary share sale.

•The valuation nearly doubles its previous $190 million valuation, following a $54 million funding round.

•Temple is developing a wearable device to measure metabolic state in real time, set for commercial launch within a year.

•The company also launched its first ESOP liquidity programme, joining nine other startups that provided employee liquidity this year.